Copyright
©The Author(s) 2020.
World J Gastroenterol. Jun 28, 2020; 26(24): 3401-3412
Published online Jun 28, 2020. doi: 10.3748/wjg.v26.i24.3401
Published online Jun 28, 2020. doi: 10.3748/wjg.v26.i24.3401
Figure 2 Potential clinical application of long noncoding RNAs as biomarkers in gastric cancer.
A: Long noncoding RNAs (lncRNAs) with dysregulated expression or variants can act as prognostic biomarkers for gastric cancer (GC) patients; B: Dysregulated lncRNAs identified from body fluids can be used to detect GC; C: Selected dysregulated lncRNAs are associated with drug resistance in GC patients, animal models, and cell lines. lncRNA: Long noncoding RNA.
- Citation: Gao Y, Wang JW, Ren JY, Guo M, Guo CW, Ning SW, Yu S. Long noncoding RNAs in gastric cancer: From molecular dissection to clinical application. World J Gastroenterol 2020; 26(24): 3401-3412
- URL: https://www.wjgnet.com/1007-9327/full/v26/i24/3401.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i24.3401